Variant report
Variant | rs743754 |
---|---|
Chromosome Location | chr3:50456059-50456060 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:50450589..50453159-chr3:50453865..50456485,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP131 | TF binding region |
rs_ID | r2[population] |
---|---|
rs1034408 | 1.00[CEU][hapmap];0.93[YRI][hapmap];0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs1034409 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs1107312 | 1.00[CEU][hapmap] |
rs1894324 | 1.00[CEU][hapmap] |
rs2157328 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.88[AFR][1000 genomes];0.82[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2187815 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2236944 | 1.00[CEU][hapmap] |
rs2236966 | 1.00[ASN][1000 genomes] |
rs2236969 | 1.00[CEU][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2236970 | 1.00[ASN][1000 genomes] |
rs2236972 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.96[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs2236976 | 0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2236977 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2236978 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs2236980 | 0.94[ASN][1000 genomes] |
rs2236982 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs2236985 | 1.00[CHB][hapmap];0.97[ASN][1000 genomes] |
rs2236990 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs2282757 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.94[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs2282761 | 0.94[ASN][1000 genomes] |
rs2298953 | 1.00[CEU][hapmap] |
rs2298954 | 1.00[CEU][hapmap] |
rs28428559 | 1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs28493735 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[ASN][1000 genomes] |
rs28580410 | 0.82[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs28593422 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs3213520 | 1.00[ASN][1000 genomes] |
rs3774753 | 1.00[CEU][hapmap] |
rs3806706 | 1.00[CEU][hapmap] |
rs4422301 | 1.00[CEU][hapmap];0.96[YRI][hapmap];1.00[EUR][1000 genomes] |
rs55790255 | 0.85[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs55876418 | 1.00[EUR][1000 genomes] |
rs55892059 | 0.86[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs56114301 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs56249615 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs56258146 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs56766970 | 1.00[EUR][1000 genomes] |
rs57405128 | 1.00[EUR][1000 genomes] |
rs57415469 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs58412961 | 0.86[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs58462551 | 0.91[ASN][1000 genomes] |
rs59012751 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs59167171 | 0.91[ASN][1000 genomes] |
rs59619552 | 1.00[ASN][1000 genomes] |
rs59790001 | 1.00[EUR][1000 genomes] |
rs60149721 | 0.87[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs60273100 | 0.88[AFR][1000 genomes];0.90[EUR][1000 genomes] |
rs60391761 | 0.97[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs60697422 | 0.84[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs61413553 | 0.86[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs61493458 | 1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6446203 | 1.00[CEU][hapmap];0.88[YRI][hapmap] |
rs6767505 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs6770258 | 1.00[CEU][hapmap];0.97[YRI][hapmap];1.00[EUR][1000 genomes] |
rs6770669 | 1.00[CEU][hapmap];0.97[YRI][hapmap];1.00[EUR][1000 genomes] |
rs73832879 | 0.87[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs73832881 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs73833363 | 0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs73833366 | 0.89[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs73833371 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs73833372 | 0.87[AFR][1000 genomes];0.82[EUR][1000 genomes] |
rs73833373 | 1.00[EUR][1000 genomes] |
rs73833386 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs73835503 | 0.86[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs73835505 | 0.86[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs743755 | 1.00[CEU][hapmap];0.96[YRI][hapmap];0.89[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs743859 | 1.00[CEU][hapmap];0.82[CHB][hapmap];1.00[JPT][hapmap];0.92[YRI][hapmap] |
rs7610830 | 1.00[CEU][hapmap];0.96[YRI][hapmap];1.00[EUR][1000 genomes] |
rs7612820 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs7625295 | 0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs7626470 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.95[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7634307 | 1.00[CEU][hapmap];0.96[YRI][hapmap];0.88[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs7636862 | 1.00[CEU][hapmap] |
rs7640842 | 0.89[AFR][1000 genomes];1.00[EUR][1000 genomes] |
rs7641224 | 1.00[CEU][hapmap] |
rs7642779 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs7647409 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];0.83[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs7649603 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs886075 | 1.00[CEU][hapmap] |
rs9311451 | 1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9311453 | 0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9311455 | 0.97[ASN][1000 genomes] |
rs9812540 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.94[ASN][1000 genomes] |
rs9814606 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.87[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9814874 | 1.00[CEU][hapmap] |
rs9817768 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9828829 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.90[YRI][hapmap];0.90[AFR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs9830408 | 1.00[CEU][hapmap] |
rs9832993 | 0.82[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9834579 | 0.91[ASN][1000 genomes] |
rs9834856 | 0.91[ASN][1000 genomes] |
rs9837658 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9837861 | 0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs9839266 | 0.91[ASN][1000 genomes] |
rs9839996 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |
rs9843693 | 0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9854585 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9863307 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |
rs9863857 | 1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[ASN][1000 genomes] |
rs9875233 | 1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[ASN][1000 genomes] |
rs9875873 | 1.00[CEU][hapmap] |
rs9880285 | 0.94[ASN][1000 genomes] |
rs9883222 | 1.00[CEU][hapmap] |
rs9883635 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.97[AFR][1000 genomes];1.00[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9990256 | 1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.90[AFR][1000 genomes];1.00[EUR][1000 genomes];0.97[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv523662 | chr3:50144951-50584999 | Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 101 gene(s) | inside rSNPs | diseases |
2 | esv1821728 | chr3:50156142-50657253 | Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 109 gene(s) | inside rSNPs | diseases |
3 | esv1793751 | chr3:50157364-50476363 | Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 98 gene(s) | inside rSNPs | diseases |
4 | esv1828162 | chr3:50157364-50506151 | Enhancers Genic enhancers Transcr. at gene 5' and 3' Flanking Active TSS Active TSS Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 98 gene(s) | inside rSNPs | diseases |
5 | nsv470561 | chr3:50158774-50584999 | Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 99 gene(s) | inside rSNPs | diseases |
6 | nsv876770 | chr3:50158774-50609624 | Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 103 gene(s) | inside rSNPs | diseases |
7 | nsv1001993 | chr3:50187646-50640808 | Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 104 gene(s) | inside rSNPs | diseases |
8 | nsv876773 | chr3:50302830-50480131 | Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 87 gene(s) | inside rSNPs | diseases |
9 | nsv834693 | chr3:50302830-50507964 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 87 gene(s) | inside rSNPs | diseases |
10 | nsv876775 | chr3:50324672-50504896 | Flanking Active TSS Weak transcription Enhancers Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 82 gene(s) | inside rSNPs | diseases |
11 | esv3584502 | chr3:50368278-50659741 | Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 55 gene(s) | inside rSNPs | diseases |
12 | nsv432419 | chr3:50388396-50637496 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
13 | nsv876778 | chr3:50413707-50465518 | Enhancers Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Genic enhancers | TF binding regionCpG islandChromatin interactive region | 13 gene(s) | inside rSNPs | diseases |
14 | nsv1013225 | chr3:50440826-50700448 | Flanking Active TSS Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
15 | nsv536566 | chr3:50440826-50700448 | Genic enhancers Weak transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 35 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:50443600-50460400 | Weak transcription | Gastric | stomach |
2 | chr3:50445600-50471400 | Weak transcription | Spleen | Spleen |
3 | chr3:50448800-50461000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:50449600-50461400 | Weak transcription | Lung | lung |
5 | chr3:50450600-50471000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:50451600-50456400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr3:50451600-50456600 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr3:50452200-50456200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
9 | chr3:50452600-50456200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr3:50454400-50460200 | Weak transcription | Brain Anterior Caudate | brain |
11 | chr3:50454800-50456600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr3:50454800-50456600 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr3:50454800-50457600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr3:50455200-50457200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
15 | chr3:50455600-50456400 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr3:50456000-50456200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
17 | chr3:50456000-50456200 | Bivalent Enhancer | Placenta | Placenta |
18 | chr3:50456000-50456600 | Enhancers | Fetal Stomach | stomach |
19 | chr3:50456000-50456800 | Enhancers | Primary monocytes fromperipheralblood | blood |